3-Amino-3-Oxopropanoic Acid

Identification

Generic Name
3-Amino-3-Oxopropanoic Acid
DrugBank Accession Number
DB02649
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 103.0767
Monoisotopic: 103.026943031
Chemical Formula
C3H5NO3
Synonyms
Not Available
External IDs
  • J135.769G
  • NSC-1812

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UMalonamidase E2Not AvailableBradyrhizobium japonicum
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as carboxylic acids. These are compounds containing a carboxylic acid group with the formula -C(=O)OH.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Carboxylic acids
Direct Parent
Carboxylic acids
Alternative Parents
Monocarboxylic acids and derivatives / Carboximidic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
Substituents
Aliphatic acyclic compound / Carbonyl group / Carboximidic acid / Carboximidic acid derivative / Carboxylic acid / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic nitrogen compound / Organic oxide / Organic oxygen compound
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
beta-alanine derivative (CHEBI:43991)
Affected organisms
Not Available

Chemical Identifiers

UNII
30H7L7X07N
CAS number
2345-56-4
InChI Key
CGJMROBVSBIBKP-UHFFFAOYSA-N
InChI
InChI=1S/C3H5NO3/c4-2(5)1-3(6)7/h1H2,(H2,4,5)(H,6,7)
IUPAC Name
2-carbamoylacetic acid
SMILES
NC(=O)CC(O)=O

References

General References
Not Available
KEGG Compound
C04131
PubChem Compound
75367
PubChem Substance
46507331
ChemSpider
67903
ChEBI
43991
ZINC
ZINC000000901948
PDBe Ligand
MLM
PDB Entries
1o9o

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility229.0 mg/mLALOGPS
logP-1.6ALOGPS
logP-1.1Chemaxon
logS0.35ALOGPS
pKa (Strongest Acidic)3.66Chemaxon
pKa (Strongest Basic)-5.9Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area80.39 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity20.81 m3·mol-1Chemaxon
Polarizability8.56 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.7321
Blood Brain Barrier+0.9717
Caco-2 permeable-0.7068
P-glycoprotein substrateNon-substrate0.8626
P-glycoprotein inhibitor INon-inhibitor0.9726
P-glycoprotein inhibitor IINon-inhibitor0.9901
Renal organic cation transporterNon-inhibitor0.9608
CYP450 2C9 substrateNon-substrate0.8581
CYP450 2D6 substrateNon-substrate0.8393
CYP450 3A4 substrateNon-substrate0.767
CYP450 1A2 substrateNon-inhibitor0.9513
CYP450 2C9 inhibitorNon-inhibitor0.9731
CYP450 2D6 inhibitorNon-inhibitor0.9553
CYP450 2C19 inhibitorNon-inhibitor0.9745
CYP450 3A4 inhibitorNon-inhibitor0.9748
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9936
Ames testNon AMES toxic0.9062
CarcinogenicityNon-carcinogens0.735
BiodegradationReady biodegradable0.8811
Rat acute toxicity1.0272 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9957
hERG inhibition (predictor II)Non-inhibitor0.9837
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-052f-9100000000-92e57f1b0778a5e37019
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-052f-9000000000-934d1ae510c8c5602ce2
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0zfr-8900000000-ee435c6a8156c9852824
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-9e4c29ab8d4f81ec17c0
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-8e131be85957017cb831
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-809e24c1347ccd8b0245
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-f3c82a25e4f6a9ba4475
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-113.9307628
predicted
DarkChem Lite v0.1.0
[M-H]-126.32185
predicted
DeepCCS 1.0 (2019)
[M+H]+114.6492628
predicted
DarkChem Lite v0.1.0
[M+H]+129.08328
predicted
DeepCCS 1.0 (2019)
[M+Na]+114.0409628
predicted
DarkChem Lite v0.1.0
[M+Na]+137.50903
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Bradyrhizobium japonicum
Pharmacological action
Unknown
General Function
Carbon-nitrogen ligase activity, with glutamine as amido-n-donor
Specific Function
Not Available
Gene Name
Not Available
Uniprot ID
Q9ZIV5
Uniprot Name
Malonamidase E2
Molecular Weight
43681.365 Da

Drug created at June 13, 2005 13:24 / Updated at August 01, 2020 13:44